Xue Guiwen – Trademark Portfolio

Entity Type: 01

Xue Guiwen holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BAOSUU, PEOLEO, SEYORZ, and AOYOTING. The owner is based in Jilin Province.

1She,Yongsheng Village,

Gongpengzi Town, Fuyu County,

Jilin Province 131200 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AOYOTING
AOYOTING
Registered 2019
BAOSUU
BAOSUU
Registered 2019
DABUWAWA
DABUWAWA
Abandoned 2019
SEYORZ
SEYORZ
Registered 2019
PEOLEO
PEOLEO
Registered 2019

Trademark Classifications

Xue Guiwen's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (4 filings)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Xue Guiwen have?

Xue Guiwen has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.

What trademark classes does Xue Guiwen file in?

Xue Guiwen files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics). Class 25 covers clothing, footwear, headgear.

What are Xue Guiwen's most well-known trademarks?

Xue Guiwen's registered trademark portfolio includes well-known marks such as BAOSUU, PEOLEO, SEYORZ, and AOYOTING. These are among 4 currently registered trademarks in the portfolio.

What is Xue Guiwen's trademark registration success rate?

Xue Guiwen has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.